TERT promoter mutation in a primary lesion of papillary thyroid carcinoma predicts absent or lower 131I uptake in a metastatic lesion

被引：0
|
作者：
Meng, Zhaowei [1 ]
机构：
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1527
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131i uptake in metastases
    Meng, Zhaowei
    Matsuse, Michiko
    Saenko, Vladimir
    Yamashita, Shunichi
    Ren, Peng
    Zheng, Xiangqian
    Jia, Qiang
    Tan, Jian
    Li, Ning
    Zheng, Wei
    Zhao, Li
    Mitsutake, Norisato
    IUBMB LIFE, 2019, 71 (07) : 1030 - 1040
  • [2] 131I Thyroid lesion dosimetry with quantitative imaging
    Richetta, E.
    Cutaia, C.
    Codegone, A.
    Garbaccio, V.
    Pellerito, R.
    Stasi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S405 - S406
  • [3] Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma
    Na, Hee Young
    Yu, Hyeong Won
    Kim, Woochul
    Moon, Jae Hoon
    Ahn, Chang Ho
    Choi, Sang Il
    Kim, Yeo Koon
    Choi, June Young
    Park, So Yeon
    CLINICAL ENDOCRINOLOGY, 2022, 97 (01) : 106 - 115
  • [4] Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake
    Mian, Caterina
    Barollo, Susi
    Pennelli, Gianmaria
    Pavan, Nicodemo
    Rugge, Massimo
    Pelizzo, Maria Rosa
    Mazzarotto, Renzo
    Casara, Dario
    Nacamulli, Davide
    Mantero, Franco
    Opocher, Giuseppe
    Busnardo, Benedetto
    Girelli, Maria Elisa
    CLINICAL ENDOCRINOLOGY, 2008, 68 (01) : 108 - 116
  • [5] False-Positive 131I Uptake After Posttraumatic Scab in a Patient With Papillary Thyroid Carcinoma
    Yang, Jun
    Zhou, Pingping
    Su, Xinhui
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : E598 - E599
  • [6] Unusual 131I Uptake Caused by Paronychia in a Patient With Papillary Thyroid Cancer
    Yang, Jun
    Pan, Zhengzhou
    Su, Xinhui
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : e357 - e358
  • [7] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Toubeau, M
    Touzery, C
    Berriolo-Riedinger, A
    Cochet, A
    Brunotte, F
    Bedenne, L
    Cercueil, JP
    Krause, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (05) : 669 - 670
  • [8] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Michel Toubeau
    Claude Touzery
    Alina Berriolo-Riedinger
    Alexandre Cochet
    François Brunotte
    Laurent Bedenne
    Jean-Pierre Cercueil
    Denis Krause
    European Journal of Nuclear Medicine, 2001, 28 : 669 - 670
  • [9] TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma
    Oh, Eun Ji
    Lee, Sohee
    Bae, Ja Seong
    Kim, Yourha
    Jeon, Sora
    Jung, Chan Kwon
    ENDOCRINE PATHOLOGY, 2017, 28 (01) : 49 - 53
  • [10] TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma
    Eun Ji Oh
    Sohee Lee
    Ja Seong Bae
    Yourha Kim
    Sora Jeon
    Chan Kwon Jung
    Endocrine Pathology, 2017, 28 : 49 - 53
12345